Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children's Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia
|
Children's Hospital Los Angeles / Markus Muschen |
Innovation Grants |
2008 |
California |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
|
Children's Hospital Los Angeles / Theresa Harned, MD |
Young Investigator Grants |
2006 |
California |
New Approaches to Neuroblastoma Therapy
|
Children's Hospital Los Angeles / Robert Seeger |
Phase I/II Infrastructure Grants |
2008 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children's Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors |
Children's Hospital Los Angeles / Mary Nelson |
Nurse Researcher Grants |
2009 |
California |
Central Venous Catheter (CVC) - Related Bloodstream Infections in Pediatric Cancer |
Children's Hospital Los Angeles / Rita Secola |
Nurse Researcher Grants |
2009 |
California |
New Approaches to Neuroblastoma Therapy (NANT) Consortium
|
Children's Hospital Los Angeles / Robert Seeger, MD |
Phase I/II Infrastructure Grants |
2006 |
California |
Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors
|
Children's Hospital Los Angeles / William May |
Innovation Grants |
2008 |
California |
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma |
Children's Hospital Los Angeles / Shahab Asgharzadeh, MD |
Innovation Grants |
2015 |
California |